Article Details

Daré Bioscience Announces Positive Phase 1 Results for DARE-HRT1

Retrieved on: 2021-06-28 12:00:00

Tags for this article:

Click the tags to see associated articles and topics

Daré Bioscience Announces Positive Phase 1 Results for DARE-HRT1. View article details on hiswai:

Excerpt

(NASDAQ:DARE), a leader in women's health innovation, today announced positive topline results from its Phase 1 clinical trial of DARE-HRT1. DARE- ...

Article found on: www.globenewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up